| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in financing activities | -12,206 | -14,147 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -1,303 | -2,149 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -5,465 | -23,275 |
| Cash and cash equivalents at beginning of period | 98,745 | - |
| Cash and cash equivalents at end of period | 93,281 | - |
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)